Back to Archived Journals » Open Access Journal of Sports Medicine » Volume 16

Patellofemoral Pain is a Multifactorial Complex Condition; Are We Missing a Multidisciplinary Approach to its Management? Time for a Paradigm Shift

Authors Gragnani BC, Hart HF, Forsyth A ORCID logo, Barton CJ, De Oliveira Silva D ORCID logo

Received 9 September 2025

Accepted for publication 30 January 2026

Published 5 February 2026 Volume 2025:16 Pages 1—13

DOI https://doi.org/10.2147/OAJSM.S517971

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Mark Williams



Bruno C Gragnani,1 Harvi F Hart,1,2 Adrienne Forsyth,3 Christian J Barton,4 Danilo De Oliveira Silva1

1La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Melbourne, VIC, Australia; 2Department of Kinesiology, Michigan State University, Lansing, MI, USA; 3School of Behavioural and Health Sciences, Australian Catholic University, Melbourne, VIC, Australia; 4Department of Physiotherapy, Podiatry, Prosthetics and Orthotics, La Trobe University, Melbourne, VIC, Australia

Correspondence: Danilo De Oliveira Silva, La Trobe Sport and Exercise Medicine Research Centre, School of Allied Health, Human Services and Sport, La Trobe University, Melbourne, Victoria, Australia, Tel +61 426 188 766, Email [email protected]

Background: Patellofemoral pain is a prevalent musculoskeletal condition characterized by persistent anterior knee pain, often exacerbated by activities that increase patellofemoral joint stress. The aetiology of patellofemoral pain is multifactorial, involving biomechanical, muscular, and psychological factors. Altered movement patterns and muscle weaknesses, particularly in the hip and knee regions, are commonly observed in people with patellofemoral pain. These impairments can either contribute to or result from the condition. Psychological factors, such as kinesiophobia and pain catastrophizing, also play a significant role in the persistence and severity of patellofemoral pain, highlighting the need for a comprehensive treatment approach.
The Problem: Patellofemoral pain imposes a considerable burden on those who leave with the condition, leading to high pain levels, impaired physical function, and reduced quality of life. The condition’s persistent nature and potential progression to patellofemoral osteoarthritis underscore the critical need for effective management strategies. Current best practices include exercise therapy and adjunct treatments, but adherence and long-term effectiveness remain challenges.
Take-Home Message: Emerging evidence suggests that addressing obesity and incorporating patient education and self-management strategies could enhance outcomes. Additionally, integrating dietary interventions targeting systemic inflammation presents a promising avenue for reducing pain and improving function. A multidisciplinary approach, involving various health professionals, is advocated to provide holistic and patient-centered care for those affected by patellofemoral pain.

Keywords: knee joint, patellofemoral pain syndrome, fear of movement, obesity, osteoarthritis, rehabilitation

Introduction: What Is Patellofemoral Pain, and How Common Is It?

Definition

Patellofemoral pain (PFP) is characterised by persistent diffuse anterior peri- and retro-patellar pain, exacerbated by activities that increase compressive and shear forces acting on the patellofemoral joint (PFJ), including squatting down, running, ascending and descending stairs.1–3 PFP is the preferred terminology based on an international consensus statement.1 However, PFP is synonymous with other terms, including anterior knee pain, patellofemoral pain syndrome, and chondromalacia patellae.

Epidemiology

Diagnosis of PFP seems to be growing over the years, with a 4% point-prevalence increase from 2007 to 2011 (18.7% to 22.7%),4 and accounting for approximately 17% of all knee pain presentations to general practice.5 PFP affects adolescents, young-, middle-aged, and older adults across various populations (eg, athletic, sports, military, and general population).4,6 Even so, there is limited epidemiological data on the incidence and prevalence of PFP.7 A recent systematic review indicated that the annual prevalence of PFP can vary from 13% to 35% depending on the population studied.6

Among the epidemiological studies included in the above-mentioned systematic review, Boling et al8 explored the incidence and prevalence of PFP in a cohort of 1525 US Naval Academy cadets who were followed for up to 2.5 years. Two hundred six cadets had a history of PFP, and 45 were newly diagnosed during the study period, yielding a prevalence of 13.5% and an incidence of 22/1000 person-years.8 The incidence rate in women was higher than in males (33/1000 vs 15/1000, respectively), with females being 2.2 times more likely to develop PFP than males. Despite being a prospective study of high methodological quality, Boling et al8 included cadets from the naval academy, thus limiting the generalizability of their findings. Roush and Bay9 evaluated 724 females from the general population to explore the prevalence of PFP. A total of 189 of the 724 females were diagnosed with PFP, leading to a prevalence of 13% in women aged between 18 and 35 years. A study conducted in the UK involving 57,555 participants aimed to describe the annual prevalence of patellofemoral disorders across the adult lifespan, with one in six participants reporting a patellofemoral disorder.5

The prevalence of PFP is also high in athletic populations. A retrospective study including 2002 runners with running-related musculoskeletal injuries found that PFP was the most common injury, affecting 331 runners, which was more than double the second most prevalent injury (ie, iliotibial band syndrome).10 Additionally, 62% of the runners diagnosed with PFP were women.10 A prospective epidemiological study found a PFP point prevalence of 16.3 per 100 adolescent basketball athletes, with an incidence rate of 1.09 per 1000 hours of exposure.11

The variability in findings regarding the incidence and prevalence of PFP may be attributable to differences in diagnostic criteria and study populations. However, a recently published consensus statement on diagnosing PFP, along with a checklist and reporting guide now indexed in the EQUATOR network, may help address this issue in the future.1,12 According to these reports, three main criteria should be considered for the diagnosis of PFP: (i) presence of anterior retro- or peri-patellar pain; (ii) exacerbation of pain in activities that overload the PFJ or when remaining seated for a long time; (iii) exclusion of other conditions that can also cause anterior knee pain (eg, patellar tendinopathy, ligament injuries).

Regardless, the high incidence and prevalence of PFP suggest that public and private settings must be prepared to manage a large number of people with PFP. In the next topics, we will describe the multifactorial characteristics of PFP, including physical and psychological impairments. Importantly, the considerable variability in incidence, prevalence, and prognosis across populations, together with heterogeneous responses to standard exercise-based treatments, suggests that PFP cannot be understood solely in biomechanical terms. Instead, it is more appropriately conceptualised as a complex condition influenced by interacting biomechanical, psychological, systemic, and lifestyle factors. In this narrative review, we (i) summarise the multifactorial background of PFP, including biomechanical, psychological, systemic and lifestyle contributors; (ii) discuss the personal and societal burden associated with this condition; and (iii) highlight potential multidisciplinary management strategies, such as patient education, psychological and nutrition-focused approaches, that could inform future clinical trials and clinical practice.

PFP Is a Complex Multifactorial Condition

The exact source of pain in people with PFP remains unknown, although several reports suggest biomechanical, structural, and psychological features may contribute to both the development and persistence of the condition, making PFP a challenging condition to manage in clinical practice.13–16

Movement Pattern and Muscular Features

Traditional pain models link PFJ overload with primary nociceptive pathways. For example, a theoretical pathomechanical model suggests that alterations in trunk and lower limb kinematics may result in abnormally elevated cartilage and bone stress,14 potentially increasing nociceptive input from joint and periarticular structures and contributing to the experience of PFP. Many cross-sectional studies have reported altered movement patterns in people with PFP during various activities that load the PFJ, such as climbing stairs, stepping down, and landing.17–19 However, a recent systematic review found conflicting findings in movement patterns during walking and running,19 and direct evidence linking specific biomechanical changes to nociceptive activity within the PFJ remains limited.

At the trunk, people with PFP present a higher ipsilateral trunk lean compared to pain-free controls during single-leg squat and landing,20 and excessive trunk flexion during running-induced fatigue.21 At the hip level, people with PFP present excessive hip adduction and hip internal rotation compared to pain-free controls during a range of functional tasks, including running, climbing stairs, and landing.22,23 At the knee level, there is consistent evidence that people with PFP ascend and descend stairs and run with reduced peak knee flexion and cadence,14,15 possibly indicating a conscious or unconscious attempt to reduce symptoms by decreasing PFJ and quadriceps loading requirements.17,18,24 Finally, at the foot level, excessive rearfoot eversion was reported during walking and stair ascent in people with PFP,25,26 possibly resulting in excessive internal rotation of the tibia and femur due to joint coupling.27 These altered movement patterns presented by people with PFP have been previously discussed as potential risk factors for the condition or adopted as a compensatory strategy to avoid pain.13,28 Because most available data are cross-sectional, it remains unclear whether these biomechanical differences represent primary physical impairments that precede symptom onset or alternative movement patterns that emerge in response to pain. It is likely that, for many individuals, the relationship is bidirectional. The clinical importance of altered movement patterns is emphasized by previous findings revealing that a greater number of kinematic alterations was associated with higher pain levels and lower functional status in people with PFP.29

Impaired muscle function is also thought to contribute to PFJ mechanics.30 Compelling evidence indicates lateral trunk, hip abductor, extensor, rotator, and knee extensor and flexor strength weakness in people with PFP compared to pain-free controls.31–35 Additionally, the hip and knee muscles of women with PFP seem to present even larger deficits in power and force steadiness than strength compared to pain-free controls.36,37 Although muscle impairments are commonly reported in people with PFP, prospective studies suggest they are not risk factors for developing the condition (an exception is knee extensor strength, which is a strong risk factor for PFP in military populations).13,35,38 Lower limb muscle activity has also been explored in PFP.32 Findings from a meta-analysis indicated that the onset of muscle activity in vastus medialis was delayed relative to vastus lateralis during stepping and stair ambulation tasks.32 A higher mean amplitude of the biceps femoral was also present in PFP compared to pain-free controls during hop tasks. Delayed or reduced activation of the gluteal muscles has also been associated with PFP.39 However, whether it affects hip control, knee alignment, or symptoms is unclear.

The wide range of movement adaptations and physical impairments observed in people with PFP poses a significant challenge for its management. Therefore, exercise professionals may need to tailor their approach when prescribing exercises for people with PFP.

Psychological Features

In isolation, the biomedical model has inherent limitations within the complex paradigm of human pain perception.40 More contemporary evidence suggests that PFP should be considered within a broader biopsychosocial framework that encompasses biomechanical, psychological, social, and lifestyle factors, all of which can influence pain perception and its maintenance.41–44 A previous PFP consensus statement involving researchers and health professionals also urged the consideration of psychological factors in research and clinical settings.45 This view aligns with other highly prevalent musculoskeletal conditions, such as knee osteoarthritis and low back pain.46,47

A growing number of studies suggest that psychological characteristics play an essential role in the persistence of musculoskeletal pain and functional limitations and represent a barrier to recovery for people with PFP.48,49 In this context, a systematic review demonstrated that psychological factors such as kinesiophobia (fear/avoidance of movement) and pain catastrophising (excessively negative feelings and thoughts regarding pain) are elevated in people with PFP compared to pain-free controls.50 Furthermore, both factors were strongly correlated with the pain and functional capacity of people with PFP.50,51 Additionally, reports indicate that reductions in fear of movement and pain catastrophising are associated with improvements in pain and function following rehabilitation.52 Considering the multifactorial nature of PFP, alterations in psychological factors may not be present in all people with PFP. Maclachlan et al50 compared psychological characteristics such as depression, fear of movement, and pain catastrophising between people with PFP and pain-free participants and did not find significant differences. However, when subgroup analyses were conducted based on the severity of PFP, considering factors such as pain level, symptoms, and functional disability, it was observed that people with more severe PFP exhibited higher levels of depression, pain catastrophising, and fear of movement than those with less severe PFP.50

Findings from a recent meta-correlation with individual patient data (>500 patients) indicated that fear of movement is associated with pain and physical function in people with PFP.48 Fear of movement has also been associated with protective biomechanical patterns (ie, reduced knee flexion in activities loading the PFJ)44,53 and manifestations of peripheral and central sensitisation (eg, local and remote pressure pain thresholds).54 The only prospective study exploring a psychological factor in people with PFP suggests that fear of movement is not a risk factor for the condition; instead, it develops as a result of living with persistent PFP.55

Beyond biomechanics and psychological characteristics, other features such as altered pain processing (eg, local and remote pressure pain hypersensitivity),56–58 sleep disturbances,59 reduced physical activity,60 and broader social factors (eg, work and family demands, access to care) are increasingly recognised as relevant contributors to pain persistence and disability in musculoskeletal conditions, including PFP. Also, overweight and obesity are increasingly recognised as relevant for people with PFP.61 Young adults with PFP often have higher body fat and lower skeletal muscle mass than pain-free controls, which is associated with impaired functional capacity and reduced hip and knee strength.62,63 These systemic characteristics and their potential links with pain sensitisation64 and joint loading are discussed in more detail in Systemic and Mechanical Factors Associated with Obesity. While comprehensive data across all these domains are still limited in PFP, recognising their potential influence is important when conceptualising PFP as a multifactorial condition and when planning multidisciplinary models of care. A conceptual overview of these multifactorial contributors and potential management targets is provided in Figure 1.

Figure 1 Conceptual model of patellofemoral pain as a multifactorial condition. The figure illustrates the interplay among biomechanical factors, psychological factors, systemic and lifestyle factors, and social context. The lower panel highlights possible multidisciplinary management components, including exercise therapy, patient education, psychological interventions, nutrition interventions, and digital health tools to facilitate long-term engagement.

Burden of Living with PFP

PFP confers a profound personal burden, including unacceptably high pain medication use65 (costing ~US$5000 in medication per person within a 2-year window after diagnosis),66 and poor quality of life.67 Combined with low social interactions and participation in physical activity,60,68 it underpins a 6-fold increased risk of depression in people with PFP.69

Impaired Daily Physical Function

PFP has a detrimental impact on the performance of daily living activities.70 Several cross-sectional studies have reported impaired performance in physical function in people with PFP compared to pain-free controls, including step-down tasks, single-leg squats, sit-to-stand, and balance tasks.34,70–73 A recent systematic review70 found that people with PFP had high pain levels (>6 out of 10 on a visual analogue scale) across ten daily physical activities. Sitting and running were two of the most painful tasks reported by this population. Therefore, adequate management of PFP is necessary to restore the physical function of people affected by this condition. In the following topic, we will summarise the evidence on prognostic studies in PFP.

Poor Prognosis and Progression to Patellofemoral Osteoarthritis

Historically, PFP was considered a self-limited condition (ie, symptoms would resolve spontaneously over time without any intervention).68 However, contemporary evidence indicates PFP has a persistent nature, with a high number of people (50 to 91%) experiencing persistent symptoms up to 18 years after the initial diagnosis.74–76 Due to its complex multifactorial aetiology, PFP represents a challenging condition to manage, with over 50% of affected individuals reporting symptom recurrence after 12 months, despite receiving interventions recommended by clinical practice guidelines.77,78 We are now recognizing that PFP is a pre-stage of knee osteoarthritis.79 And, people living with chronic PFP are actually in an early non-traumatic osteoarthritis stage.

Two clinical trials exploring prognostic factors associated with PFP reported that people with longer symptom duration and lower self-reported functional capacity (reflected by lower scores on the Anterior Knee Pain Scale, AKPS) had worse prognosis both at one-year and 5 to 8-year follow-ups.78,80 Therefore, identifying factors associated with chronicity and more severe symptoms is crucial for designing preventive strategies that aim to improve the long-term prognosis of PFP.

The persistent and recurrent nature of PFP is particularly important, as others have suggested that PFP may be a precursor to patellofemoral osteoarthritis.81,82 In a retrospective study of 118 individuals who underwent patellofemoral arthroplasty for isolated patellofemoral osteoarthritis, approximately 22% reported anterior knee pain since adolescence, compared with only 6% in the control group of 116 individuals who underwent medial tibiofemoral arthroplasty.83 Thorstensson and colleagues84 assessed 84 individuals with PFP (without signs of patellofemoral osteoarthritis) and found that 31% of the participants developed patellofemoral osteoarthritis at the end of the 7-year follow-up period. Another important factor that supports this progression lies in the similarity between the symptoms and biomechanical changes of both conditions.82 One of the main clinical symptoms of patellofemoral osteoarthritis, characterised by anterior knee pain during activities that load the patellofemoral joint (eg, squatting, stair climbing/descending), is similar to the typical manifestation of PFP.82 Additionally, studies demonstrate biomechanical and muscular alterations in both PFP and patellofemoral osteoarthritis, including reduced maximum torque of knee extensors and hip abductors, and reduced lower-limb muscle power.82,85,86 Altered biomechanics of the lower limbs can lead to abnormal loading on the PFJ, which in younger people may manifest as PFP and, over the long term, may lead to structural damage, ultimately progressing to patellofemoral osteoarthritis.81

The primary hypothesis linking PFP presence to the future development of patellofemoral osteoarthritis is abnormal PFJ loading.82 Consequently, identifying factors that may exacerbate PFP symptoms and drive the progression of this condition is of utmost importance for the development and adoption of preventive treatment strategies, thereby mitigating the impacts of patellofemoral osteoarthritis on those affected and on healthcare systems’ costs.66 In this regard, obesity may be a significant factor warranting exploration. Although widely studied in people with knee osteoarthritis and identified as one of the main risk factors for its development,87 the impact of obesity on PFP has been poorly addressed. While higher body mass increases PFJ loading, obesity is also associated with osteoarthritis in non-weight-bearing joints such as the hands,88 indicating that systemic effects of excess adipose tissue (eg, low-grade inflammation and adipokine activity) are likely to play a key role.88

What are We Missing in PFP Management?

The current best management for PFP, as reported by international consensus statements and clinical practice guidelines, includes exercise therapy and adjunct strategies (eg, movement retraining, taping, foot orthoses, bracing, etc).89–92 However, as discussed in the previous section, while these strategies demonstrate short-term effectiveness, their benefits are not often sustained over the medium to long term (more than 1 year). This raises the question, What are we missing? Several areas warrant further investigation to enhance outcomes for people with PFP, including: (i) poor adherence to exercise-based interventions; (ii) lack of knowledge on patient education and self-management strategies; (iii) systemic and mechanical factors associated with overweight and obesity.

Poor Adherence to Exercise-Based Interventions

The importance of adherence has been described as a crucial factor for the success of PFP management.93 This is perhaps because most prior exercise programs have not been co-designed with end-users, which may explain persistent impairments, treatment ineffectiveness, and lack of adherence. Convenience, access, and lack of engaging resources are the most common barriers to exercise adherence in patients with musculoskeletal conditions.94 Previous work indicated that adherence to 12 or more exercise and education sessions is associated with a 3.3 times greater likelihood of recovery, compared to not adhering (less than 12 sessions) at a 4-month follow-up in young adults with PFP.95 Adolescents with an adherence rate greater than 70% are 4 times more likely to be recovered (ie, completely recovered or strongly recovered on a Likert scale) at 12 months after exercise therapy than adolescents with an adherence rate lower than 70%.93 This work also reported that adolescents who completed the exercise program 3 times per week were 4.4 times more likely to recover compared to those completing the exercise program less than 3 times per week.93 Notably, these adherence data relate to follow-up periods of up to 12 months, and it remains unknown whether the superior outcomes observed in highly adherent patients are sustained over the longer term, reinforcing the need for future trials with extended follow-up.

Recent advances in digital technologies (eg, telerehabilitation) offer promising opportunities for creating co-designed multimedia online resources to assist in the management of PFP.96,97 This innovative approach could yield an effective, highly scalable management strategy to improve treatment adherence at a low cost. Telerehabilitation has shown positive effects across many orthopaedic conditions.98,99 For example, a web-based exercise program was deemed feasible for PFP as an alternative when face-to-face consultations were a barrier to adherence.95 A recent meta-analysis also suggested that remote rehabilitation facilitated by text messages, phone calls, apps, or web-based programs may lead to greater adherence than face-to-face appointments.99 However, before making definitive recommendations regarding its potential value, large and high-quality randomised controlled trials in the PFP field are needed.

Lack of Knowledge of Patient Education and Self-Management Strategies

In 2018, patient education for PFP was described in an editorial as “potentially potent and essential, but under-researched”. This was reinforced by qualitative findings from health professionals managing people with PFP, who stated that patient education is a core intervention for this population.43 In 2020, promising findings were reported in a systematic review suggesting that when delivered by health professionals, patient education led to similar improvements in pain and self-reported physical function compared to exercise therapy, with a lower number of sessions (2 education sessions on average compared to 20 exercise-therapy sessions).41 Despite “calls to action” from researchers and health professionals, there is no strong evidence to support patient education in consensus statements or clinical practice guidelines for the management of PFP.1,89,91

An important component of patient education is to empower people with PFP with self-management strategies.41 Episodes of pain flares can disengage patients from their rehabilitation journey, leaving them more likely to have recurrence and persistent symptoms. Qualitative reports suggest that a lack of knowledge of self-management strategies and poor experiences with a health professional are the main reasons for people with PFP to disengage with rehabilitation.100 Again, digital health may be a feasible option for patients to learn about their condition and self-management strategies, and could be a valuable tool for health professionals to use alongside face-to-face consultations. Additionally, it could provide accessibility to high-quality care for people living in remote areas.

Findings from a clinical feasibility trial95 indicate that 31% (11/35) of participants with PFP reported pain flares or muscle soreness during an exercise program, with most events occurring in the first week. Assisted by a self-directed online platform including education on self-management strategies, the number of pain flares over 6 weeks of the exercise program was significantly reduced. Improvements in the participants’ ability to independently manage exercise loads or ongoing active management leading to improved knee self-efficacy may explain these findings. Therefore, we recommend that previously developed and tested educational resources (eg, https://mykneecap.trekeducation.org/) should be used by health professionals and be made readily available to patients with PFP during their rehabilitation journey. We also encourage the co-development of new digital tools with end-users.

Systemic and Mechanical Factors Associated with Obesity

Another factor that has been neglected in PFP interventional studies is the influence of obesity in people with PFP.63,101 In the past four decades, the number of adults with obesity worldwide has increased more than six times, with 38% of the general population with PFP living with overweight or obesity.62 This is critical for people with PFP, who have higher body fat and lower skeletal muscle mass than pain-free controls, which are associated with impaired functional capacity and hip and knee strength.62

Beyond the mechanical load on knees, it is important to highlight that obesity can also generate systemic and local inflammation as a consequence of the higher amount of body fat.102 Additionally, high signal intensity of the Hoffa fat pad was observed in people with PFP, which is a sign of local inflammation.103 Evidence suggests that obesity increases the risk of the development of osteoarthritis in non-weight-bearing joints (eg, hand osteoarthritis).104,105 This reinforces that mechanical overload alone cannot explain this relationship. Systemic changes, such as the production of adipokines by adipose tissue, like leptin,106 and the amplification of the inflammatory profile due to increased production of interleukin-6107 and tumor necrosis factor-alpha,108 are associated with detrimental effects on patellar cartilage (eg, reduction in patellar cartilage volume) and pain, and may mediate this relationship.109,110 In addition, low-grade systemic inflammation related to excess adipose tissue may influence central pain processing, for example, by facilitating nociceptive transmission at spinal and supraspinal levels, and has been linked to manifestations of pain sensitisation in people with knee disorders.111 Together, these mechanical and systemic mechanisms position obesity as a key systemic contributor to the multifactorial background of PFP and a potentially important target for multidisciplinary management.

Since obesity is a modifiable factor, further investigation is warranted and may yield valuable clinical information. Current guidelines and recommendations for the treatment of PFP do not address the impact of obesity on the development and management of PFP or the long-term effectiveness of interventions.28,43,90,112 The literature provides strong evidence suggesting that people with knee osteoarthritis benefit from dietary interventions to improve pain, physical function, and general health,113,114 all of which may relate to obesity; yet, nothing is known about the effect of dietary interventions in people with PFP.

Diet/Nutrition Programs Applied to Musculoskeletal Conditions

While addressing the systemic and mechanical factors associated with obesity in PFP, a critical aspect to consider is the implementation of effective dietary interventions specifically tailored for people with knee conditions. The traditional approach to weight loss, which primarily focuses on generating an energy deficit through caloric restriction and increased physical activity, faces practical challenges in implementation, especially for people with persistent knee pain.

Beyond conventional weight-loss strategies, emerging evidence suggests the potential of nutrition strategies that directly target systemic inflammation.115,116 Unlike energy-deficient methods, these dietary approaches aim to mitigate inflammatory processes linked to knee conditions, including PFP.56,103 For instance, diets rich in anti-inflammatory foods—such as those containing omega-3 fatty acids, antioxidants, and phytochemicals—could play a crucial role.116,117 These nutrients are known to reduce the production of pro-inflammatory cytokines such as interleukin-6 and tumour necrosis factor-alpha, which are implicated in patellar cartilage degradation and increased knee pain.118,119

Anti-inflammatory dietary interventions are not focused on weight loss but on altering the body’s inflammatory response, which could lead to more immediate physiological benefits.120 This approach may be particularly beneficial for people with knee conditions, where reducing inflammation can lead to decreased pain and improved physical function, encouraging greater long-term treatment adherence and outcomes.

The potential of dietary interventions in managing PFP warrants further investigation. It is essential to explore interventions that address the inflammatory processes and overall joint health. This is highlighted by a recent trial that found telehealth-delivered programs targeting exercise with dietary intervention for people with knee osteoarthritis are likely to be cost-effective, particularly if potential long-term gains from weight loss and work productivity are considered.121

Is It Time for a Paradigm Shift in How We Manage PFP?

PFP has been receiving greater attention from the research and clinical community due to its burden on adolescents and young adults.89 International consensus statements and clinical practice guidelines report that current management options (eg, exercise, taping, foot orthoses) lead to positive short-term outcomes.89,91 However, these management options are unsuccessful in the medium- and long-term.80 Therefore, it is perhaps time to rethink our management strategies and propose clinical trials that address the gaps highlighted in the previous section.

A recent evidence gap map on interventions showed that existing research is heavily skewed toward physical interventions and outcomes focused on pain and physical function. There is a clear need for higher-quality studies examining both physical and non-physical interventions across a broader spectrum of outcomes. Additionally, most studies to date have evaluated only short-term effects.122

Considering the psychological features that have been consistently reported in people with PFP,50 and that a large part of this population lives with overweight or obesity.62–64 It is time for a paradigm shift, exploring a multi-disciplinary approach involving health professionals such as clinical counsellors, psychologists, dietitians, physicians, physiotherapists, and exercise physiologists. Interventions such as dietary interventions and cognitive behavioural therapy present promising results in other populations when delivered in person or via telehealth (eg, knee osteoarthritis,114,117,123 low back pain124), and should be investigated in people with PFP. Such an approach has the potential to revolutionize the current management of PFP. For example, future trials could compare traditional exercise-based physiotherapy with integrated models that combine physiotherapy-led exercise and movement retraining with psychology-led cognitive behavioural therapy and dietitian-led anti-inflammatory or weight-management nutrition programs. Co-ordinated care pathways that embed digital education and telehealth follow-up across disciplines may also be explored. Such an approach has the potential to revolutionize the current management of PFP, offering more holistic and patient-centred strategies.

Conclusion

PFP is a highly prevalent, persistent, and burdensome condition with a complex multifactorial background that includes biomechanical, psychological, systemic, and lifestyle contributors. Contemporary management, which predominantly targets local biomechanical impairments with exercise and adjunct physical interventions, provides short-term benefits but limited long-term relief. Emerging evidence on psychological factors, obesity, diet, digital health, patient education, and self-management highlights the need to broaden our therapeutic focus. We propose that future research and clinical practice prioritise multidisciplinary, patient-centred models of care that integrate exercise therapy, education, psychological support, and nutrition interventions to improve long-term outcomes for people living with PFP.

Disclosure

The authors report no conflicts of interest in this work.

References

1. Crossley KM, Stefanik JJ, Selfe J, et al. 2016 Patellofemoral pain consensus statement from the 4th International Patellofemoral Pain Research Retreat, Manchester. Part 1: terminology, definitions, clinical examination, natural history, patellofemoral osteoarthritis and patient-reported outcome measures. Br J Sports Med. 2016;50(14):839–13. doi:10.1136/bjsports-2016-096384

2. Van Tiggelen D, Cowan S, Coorevits P, Duvigneaud N, Witvrouw E. Delayed vastus medialis obliquus to vastus lateralis onset timing contributes to the development of patellofemoral pain in previously healthy men: a prospective study. Am J Sports Med. 2009;37(6):1099–1105. doi:10.1177/0363546508331135

3. Crossley KM, van Middelkoop M, Barton CJ, Culvenor AG. Rethinking patellofemoral pain: prevention, management and long-term consequences. Best Pract Res Clin Rheumatol. 2019;33(1):48–65. doi:10.1016/j.berh.2019.02.004

4. Glaviano NRK, Hart M. Demographic and epidemiological trends in patellofemoral pain. IJSPT. 2015;10(3):281–290.

5. Wood L, Muller S, Peat G. The epidemiology of patellofemoral disorders in adulthood: a review of routine general practice morbidity recording. Prim Health Care Res Dev. 2011;12(2):157–164. doi:10.1017/S1463423610000460

6. Smith BE, Selfe J, Thacker D, et al. Incidence and prevalence of patellofemoral pain: a systematic review and meta-analysis. PLoS One. 2018;13(1):e0190892. doi:10.1371/journal.pone.0190892

7. Chia L, De Oliveira Silva D, Whalan M, et al. Epidemiology of gradual-onset knee injuries in team ball-sports: a systematic review with meta-analysis of prevalence, incidence, and burden by sex, sport, age, and participation level. J Sci Med Sport. 2022;25(10):834–844. doi:10.1016/j.jsams.2022.08.016

8. Boling M, Padua D, Marshall S, Guskiewicz K, Pyne S, Beutler A. Gender differences in the incidence and prevalence of patellofemoral pain syndrome. Scand J Med Sci Sports. 2010;20(5):725–730. doi:10.1111/j.1600-0838.2009.00996.x

9. Roush RJCB. Prevalence of anterior knee pain in 18-35 year-old females. IJSPT. 2012;7(4):396–491.

10. Taunton JE, Ryan MB, Clement DB, et al. A retrospective case-control analysis of 2002 running injuries. Br J Sports Med. 2002;36(95):–101.

11. Myer GD, Ford KR, Barber Foss KD, et al. The incidence and potential pathomechanics of patellofemoral pain in female athletes. Clin Biomech. 2010;25(7):700–707. doi:10.1016/j.clinbiomech.2010.04.001

12. Barton CJ, De Oliveira Silva D, Morton S, et al. REPORT-PFP: a consensus from the international patellofemoral research network to improve reporting of quantitative patellofemoral pain studies. Br J Sports Med. 2021;55(20):1135–1143. doi:10.1136/bjsports-2020-103700

13. Neal BS, Lack SD, Lankhorst NE, Raye A, Morrissey D, van Middelkoop M. Risk factors for patellofemoral pain: a systematic review and meta-analysis. Br J Sports Med. 2019;53(5):270–281. doi:10.1136/bjsports-2017-098890

14. Powers CM, Witvrouw E, Davis IS, Crossley KM. Evidence-based framework for a pathomechanical model of patellofemoral pain: 2017 patellofemoral pain consensus statement from the 4th International Patellofemoral Pain Research Retreat, Manchester, UK: part 3. Br J Sports Med. 2017;51(24):1713–1723. doi:10.1136/bjsports-2017-098717

15. De Oliveira Silva D, Magalhaes FH, Faria NC, et al. Lower amplitude of the hoffmann reflex in women with patellofemoral pain: thinking beyond proximal, local, and distal factors. Arch Phys Med Rehabil. 2016;97(7):1115–1120. doi:10.1016/j.apmr.2015.12.017

16. Pazzinatto MF, de Oliveira Silva D, Pappas E, Magalhaes FH, de Azevedo FM. Is quadriceps H-reflex excitability a risk factor for patellofemoral pain? Med Hypotheses. 2017;108:124–127. doi:10.1016/j.mehy.2017.08.019

17. De Oliveira Silva D, Briani RV, Pazzinatto MF, Ferrari D, Aragao FA, Azevedo FM. Reduced knee flexion is a possible cause of increased loading rates in individuals with patellofemoral pain. Clin Biomech. 2015;30(9):971–975. doi:10.1016/j.clinbiomech.2015.06.021

18. De Oliveira Silva D, Barton CJ, Pazzinatto MF, Briani RV, de Azevedo FM. Proximal mechanics during stair ascent are more discriminate of females with patellofemoral pain than distal mechanics. Clin Biomech. 2016;35:56–61. doi:10.1016/j.clinbiomech.2016.04.009

19. Bazett-Jones DM, Neal BS, Legg C, Hart HF, Collins NJ, Barton CJ. Kinematic and kinetic gait characteristics in people with patellofemoral pain: a systematic review and meta-analysis. Sports Med. 2023;53(2):519–547. doi:10.1007/s40279-022-01781-1

20. Nakagawa TH, Maciel CD, Serrao FV. Trunk biomechanics and its association with hip and knee kinematics in patients with and without patellofemoral pain. Man Ther. 2015;20(1):189–193. doi:10.1016/j.math.2014.08.013

21. Teng HL, Strength PCMH-E. Trunk posture, and use of the knee-extensor muscles during running. J Athl Train. 2016;51(7):519–524. doi:10.4085/1062-6050-51.8.05

22. Meira EP, Brumitt J. Influence of the hip on patients with patellofemoral pain syndrome: a systematic review. Sports Health. 2011;3(5):455–465. doi:10.1177/1941738111415006

23. Souza RB, Powers CM. Differences in hip kinematics, muscle strength, and muscle activation between subjects with and without patellofemoral pain. J Orthop Sports Phys Ther. 2009;39(1):12–19. doi:10.2519/jospt.2009.2885

24. Lankhorst NE, Bierma-Zeinstra SM, van Middelkoop M. Factors associated with patellofemoral pain syndrome: a systematic review. Br J Sports Med. 2013;47(4):193–206. doi:10.1136/bjsports-2011-090369

25. Dowling GJ, Murley GS, Munteanu SE, et al. Dynamic foot function as a risk factor for lower limb overuse injury: a systematic review. J Foot Ankle Res. 2014;7(1):53. doi:10.1186/s13047-014-0053-6

26. De Oliveira Silva D, Briani RV, Pazzinatto MF, et al. Reliability and differentiation capability of dynamic and static kinematic measurements of rearfoot eversion in patellofemoral pain. Clin Biomech. 2015;30(2):144–148. doi:10.1016/j.clinbiomech.2014.12.009

27. Tiberio D. The effect of excessive subtalar joint pronation on patellofemoral mechanics: a theoretical model. J Orthop Sports Phys Ther. 1987;9(4):160–165.

28. Lack S, Neal B, De Oliveira Silva D, Barton C. How to manage patellofemoral pain - Understanding the multifactorial nature and treatment options. Phys Ther Sport. 2018;32:155–166. doi:10.1016/j.ptsp.2018.04.010

29. Ferrari D, Briani RV, De Oliveira Silva D, et al. Higher pain level and lower functional capacity are associated with the number of altered kinematics in women with patellofemoral pain. Gait Posture. 2018;60:268–272. doi:10.1016/j.gaitpost.2017.07.034

30. Chiu JK, Wong YM, Yung PS, Ng GY. The effects of quadriceps strengthening on pain, function, and patellofemoral joint contact area in persons with patellofemoral pain. Am J Phys Med Rehabil. 2012;91(2):98–106. doi:10.1097/PHM.0b013e318228c505

31. Briani RV, De Oliveira Silva D, Ducatti MHM, et al. Knee flexor strength and rate of torque development deficits in women with patellofemoral pain are related to poor objective function. Gait Posture. 2021;83:100–106. doi:10.1016/j.gaitpost.2020.10.011

32. Alsaleh SA, Murphy NA, Miller SC, Morrissey D, Lack SD. Local neuromuscular characteristics associated with patellofemoral pain: a systematic review and meta-analysis. Clin Biomech. 2021;90:105509. doi:10.1016/j.clinbiomech.2021.105509

33. Cowan SM, Crossley KM, Bennell KL. Altered Hip and trunk muscle function in individuals with patellofemoral pain. Br J Sports Med. 2009;43(8):584–588. doi:10.1136/bjsm.2008.053553

34. Nunes GS, De Oliveira Silva D, Crossley KM, Serrao FV, Pizzari T, Barton CJ. People with patellofemoral pain have impaired functional performance, that is correlated to hip muscle capacity. Phys Ther Sport. 2019;40:85–90. doi:10.1016/j.ptsp.2019.08.010

35. Van Cant J, Pineux C, Pitance L, Feipel V. Hip muscle strength and endurance in females with patellofemoral pain: a systematic review with meta-analysis. Int J Sports Phys Ther. 2014;9(5):564–582.

36. Ferreira AS, De Oliveira Silva D, Ferrari D, et al. Knee and Hip isometric force steadiness are impaired in women with patellofemoral pain. J Strength Cond Res. 2021;35(10):2878–2885.

37. Ferreira AS, De Oliveira Silva D, Barton C, et al. Impaired isometric, concentric, and eccentric rate of torque development at the Hip and knee patellofemoral pain. J Strength Cond Res. 2021;35(9):2492–2497 doi:10.1519/JSC.0000000000003179.

38. Rathleff MS, Rathleff CR, Crossley KM, Barton CJ. Is Hip strength a risk factor for patellofemoral pain? A systematic review and meta-analysis. Br J Sports Med. 2014;48(14):1088. doi:10.1136/bjsports-2013-093305

39. Barton CJ, Lack S, Malliaras P, Morrissey D. Gluteal muscle activity and patellofemoral pain syndrome: a systematic review. Br J Sports Med. 2013;47(4):207–214. doi:10.1136/bjsports-2012-090953

40. Woolf CJ. What to call the amplification of nociceptive signals in the central nervous system that contribute to widespread pain? Pain. 2014;155(10):1911–1912. doi:10.1016/j.pain.2014.07.021

41. De Oliveira Silva D, Pazzinatto MF, Rathleff MS, et al. Patient education for patellofemoral pain: a systematic review. J Orthop Sports Phys Ther. 2020;50(7):388–396. doi:10.2519/jospt.2020.9400

42. Barton CJ, Crossley KM. Sharing decision-making between patient and clinician: the next step in evidence-based practice for patellofemoral pain? Br J Sports Med. 2016;50(14):833–834. doi:10.1136/bjsports-2015-095607

43. Barton CJ, Lack S, Hemmings S, Tufail S, Morrissey D. The ‘Best Practice Guide to Conservative Management of Patellofemoral Pain’: incorporating level 1 evidence with expert clinical reasoning. Br J Sports Med. 2015;49(14):923–934. doi:10.1136/bjsports-2014-093637

44. De Oliveira Silva D, Barton CJ, Briani RV, et al. Kinesiophobia, but not strength is associated with altered movement in women with patellofemoral pain. Gait Posture. 2019;68:1–5. doi:10.1016/j.gaitpost.2018.10.033

45. Vicenzino BT, Rathleff MS, Holden S, et al. Developing clinical and research priorities for pain and psychological features in people with patellofemoral pain: an international consensus process with health care professionals. J Orthop Sports Phys Ther. 2022;52(1):29–39. doi:10.2519/jospt.2022.10647

46. Wise BL, Niu J, Zhang Y, et al. Psychological factors and their relation to osteoarthritis pain. Osteoarthritis Cartilage. 2010;18(7):883–887. doi:10.1016/j.joca.2009.11.016

47. Alhowimel A, AlOtaibi M, Radford K, Coulson N. Psychosocial factors associated with change in pain and disability outcomes in chronic low back pain patients treated by physiotherapist: a systematic review. SAGE Open Med. 2018;6:2050312118757387. doi:10.1177/2050312118757387

48. Rethman KK, Mansfield C, Moeller J, et al. Kinesiophobia is associated with poor function and modifiable through interventions in people with patellofemoral pain: a systematic review with individual participant data correlation meta-analysis. Phys Ther. 2023. doi:10.1093/ptj/pzad074

49. Priore LB, Lack S, Garcia C, Azevedo FM, De Oliveira Silva D. Two weeks of wearing a knee brace compared with minimal intervention on kinesiophobia at 2 and 6 weeks in people with patellofemoral pain: a randomized controlled trial. Arch Phys Med Rehabil. 2020;101(4):613–623. doi:10.1016/j.apmr.2019.10.190

50. Maclachlan LR, Collins NJ, Matthews MLG, Hodges PW, Vicenzino B. The psychological features of patellofemoral pain: a systematic review. Br J Sports Med. 2017;51(9):732–742. doi:10.1136/bjsports-2016-096705

51. Domenech J, Sanchis-Alfonso V, Lopez L, Espejo B. Influence of kinesiophobia and catastrophizing on pain and disability in anterior knee pain patients. Knee Surg Sports Traumatol Arthrosc. 2013;21(7):1562–1568. doi:10.1007/s00167-012-2238-5

52. Domenech J, Sanchis-Alfonso V, Espejo B. Changes in catastrophizing and kinesiophobia are predictive of changes in disability and pain after treatment in patients with anterior knee pain. Knee Surg Sports Traumatol Arthrosc. 2014;22(10):2295–2300. doi:10.1007/s00167-014-2968-7

53. De Oliveira Silva D, Willy RW, Barton CJ, Christensen K, Pazzinatto MF, Azevedo FM. Pain and disability in women with patellofemoral pain relate to kinesiophobia, but not to patellofemoral joint loading variables. Scand J Med Sci Sports. 2020;30(11):2215–2221. doi:10.1111/sms.13767

54. Pazzinatto MF, De Oliveira Silva D, Willy RW, Azevedo FM, Barton CJ. Fear of movement and (re)injury is associated with condition specific outcomes and health-related quality of life in women with patellofemoral pain. Physiother Theory Pract. 2022;38(9):1254–1263. doi:10.1080/09593985.2020.1830323

55. Pazzinatto MF, Barton CJ, Willy RW, Ferreira AS, Azevedo FM, De Oliveira Silva D. Are physical function and fear of movement risk factors for patellofemoral pain? A 2-year prospective study. J Sport Rehabil. 2023;32(1):24–30. doi:10.1123/jsr.2021-0392

56. De Oliveira Silva D, Rathleff MS, Petersen K, Azevedo FM, Barton CJ. Manifestations of pain sensitization across different painful knee disorders: a systematic review including meta-analysis and metaregression. Pain Med. 2019;20(2):335–358. doi:10.1093/pm/pny177

57. Pazzinatto MF, De Oliveira Silva D, Pradela J, Coura MB, Barton C, de Azevedo FM. Local and widespread hyperalgesia in female runners with patellofemoral pain are influenced by running volume. J Sci Med Sport. 2017;20(4):362–367. doi:10.1016/j.jsams.2016.09.004

58. Pazzinatto MF, De Oliveira Silva D, Barton C, Rathleff MS, Briani RV, de Azevedo FM. Female adults with patellofemoral pain are characterized by widespread hyperalgesia, which is not affected immediately by patellofemoral joint loading. Pain Med. 2016;17(10):1953–1961. doi:10.1093/pm/pnw068

59. Larsson SC, Hallstrom E, Michaelsson K, Titova OE. Poor sleep is associated with lower physical activity in a population-based cohort of middle-aged and older adults. Sci Rep. 2025;15(1):26012. doi:10.1038/s41598-025-10991-2

60. Glaviano NR, Baellow A, Saliba S. Physical activity levels in individuals with and without patellofemoral pain. Phys Ther Sport. 2017;27:12–16. doi:10.1016/j.ptsp.2017.07.002

61. Hart HF, Patterson BE, Crossley KM, et al. May the force be with you: understanding how patellofemoral joint reaction force compares across different activities and physical interventions-a systematic review and meta-analysis. Br J Sports Med. 2022;56(9):521–530. doi:10.1136/bjsports-2021-104686

62. Ferreira AS, Mentiplay BF, Taborda B, Pazzinatto MF, de Azevedo FM, De Oliveira Silva D. Overweight and obesity in young adults with patellofemoral pain: impact on functional capacity and strength. J Sport Health Sci. 2023;12(2):202–211. doi:10.1016/j.jshs.2020.12.002

63. Ferreira AS, Mentiplay BF, Taborda B, Pazzinatto MF, de Azevedo FM, De Oliveira Silva D. Exploring overweight and obesity beyond body mass index: a body composition analysis in people with and without patellofemoral pain. J Sport Health Sci. 2023;12(5):630–638. doi:10.1016/j.jshs.2021.06.003

64. Ferreira AS, Lack S, Taborda B, Pazzinatto MF, de Azevedo FM, De Oliveira Silva D. Body fat and skeletal muscle mass, but not body mass index, are associated with pressure hyperalgesia in young adults with patellofemoral pain. Braz J Phys Ther. 2022;26(4):100430. doi:10.1016/j.bjpt.2022.100430

65. Andreucci A, Roos EM, Rasmussen S, et al. Analgesic use in adolescents with patellofemoral pain or Osgood-Schlatter Disease: a secondary cross-sectional analysis of 323 subjects. Scand J Pain. 2022;22(3):543–551. doi:10.1515/sjpain-2021-0121

66. Garcia AN, Cook CE, Rhon DI. Adherence to stepped care for management of musculoskeletal knee pain leads to lower health care utilization, costs, and recurrence. Am J Med. 2021;134(3):351–360e1. doi:10.1016/j.amjmed.2020.08.006

67. Coburn SL, Barton CJ, Filbay SR, Hart HF, Rathleff MS, Crossley KM. Quality of life in individuals with patellofemoral pain: a systematic review including meta-analysis. Phys Ther Sport. 2018;33:96–108. doi:10.1016/j.ptsp.2018.06.006

68. Rathleff MS, Rathleff CR, Olesen JL, Rasmussen S, Roos EM. Is knee pain during adolescence a self-limiting condition? Prognosis of patellofemoral pain and other types of knee pain. Am J Sports Med. 2016;44(5):1165–1171. doi:10.1177/0363546515622456

69. Wride J, Bannigan K. Investigating the prevalence of anxiety and depression in people living with patellofemoral pain in the UK: the Dep-Pf Study. Scand J Pain. 2019;19(2):375–382. doi:10.1515/sjpain-2018-0347

70. Glaviano NR, Bazett-Jones DM, Boling MC. Pain severity during functional activities in individuals with patellofemoral pain: a systematic review with meta-analysis. J Sci Med Sport. 2022;25(5):399–406. doi:10.1016/j.jsams.2022.01.004

71. Priore LB, Azevedo FM, Pazzinatto MF, et al. Influence of kinesiophobia and pain catastrophism on objective function in women with patellofemoral pain. Phys Ther Sport. 2019;35:116–121. doi:10.1016/j.ptsp.2018.11.013

72. Piva SR, Fitzgerald GK, Irrgang JJ, et al. Associates of physical function and pain in patients with patellofemoral pain syndrome. Arch Phys Med Rehabil. 2009;90(2):285–295. doi:10.1016/j.apmr.2008.08.214

73. Nunes GS, De Oliveira Silva D, Pizzari T, Serrao FV, Crossley KM, Barton CJ. Clinically measured hip muscle capacity deficits in people with patellofemoral pain. Phys Ther Sport. 2019;35:69–74. doi:10.1016/j.ptsp.2018.11.003

74. Rathleff CR, Olesen JL, Roos EM, Rasmussen S, Rathleff MS. Half of 12-15-year-olds with knee pain still have pain after one year. Dan Med J. 2013;60(11):A4725.

75. Stathopulu E, Baildam E. Anterior knee pain: a long-term follow-up. Rheumatology. 2003;42(2):380–382. doi:10.1093/rheumatology/keg093

76. Nimon G, Murray D, Sandow M, Goodfellow J. Natural history of anterior knee pain: a 14- to 20-year follow-up of nonoperative management. J Pediatr Orthop. 1998;18(1):118–122.

77. Holden S, Rathleff MS, Jensen MB, Barton CJ. How can we implement exercise therapy for patellofemoral pain if we don’t know what was prescribed? A systematic review. Br J Sports Med. 2018;52(6):385. doi:10.1136/bjsports-2017-097547

78. Collins NJ, Bierma-Zeinstra SM, Crossley KM, van Linschoten RL, Vicenzino B, van Middelkoop M. Prognostic factors for patellofemoral pain: a multicentre observational analysis. Br J Sports Med. 2013;47(4):227–233. doi:10.1136/bjsports-2012-091696

79. De Oliveira Silva D, Webster KE, Feller JA, McClelland JA. Anterior knee pain following primary unilateral total knee arthroplasty with posterior-stabilized prosthesis and patellar resurfacing: prevalence and clinical implications. J Arthroplasty. 2023;38(2):281–285. doi:10.1016/j.arth.2022.08.042

80. Lankhorst NE, van Middelkoop M, Crossley KM, et al. Factors that predict a poor outcome 5-8 years after the diagnosis of patellofemoral pain: a multicentre observational analysis. Br J Sports Med. 2016;50(14):881–886. doi:10.1136/bjsports-2015-094664

81. Crossley KM. Is patellofemoral osteoarthritis a common sequela of patellofemoral pain? Br J Sports Med. 2014;48(6):409–410. doi:10.1136/bjsports-2014-093445

82. Wyndow N, Collins N, Vicenzino B, Tucker K, Crossley K. Is there a biomechanical link between patellofemoral pain and osteoarthritis? A narrative review. Sports Med. 2016;46(12):1797–1808. doi:10.1007/s40279-016-0545-6

83. Utting MR, Davies G, Newman JH. Is anterior knee pain a predisposing factor to patellofemoral osteoarthritis? Knee. 2005;12(5):362–365. doi:10.1016/j.knee.2004.12.006

84. Thorstensson CA, Andersson ML, Jonsson H, Saxne T, Petersson IF. Natural course of knee osteoarthritis in middle-aged subjects with knee pain: 12-year follow-up using clinical and radiographic criteria. Ann Rheum Dis. 2009;68(12):1890–1893. doi:10.1136/ard.2008.095158

85. Nunes GS, Barton CJ, Serrao FV. Hip rate of force development and strength are impaired in females with patellofemoral pain without signs of altered gluteus medius and maximus morphology. J Sci Med Sport. 2018;21(2):123–128. doi:10.1016/j.jsams.2017.05.014

86. Reid KF, Price LL, Harvey WF, et al. Muscle power is an independent determinant of pain and quality of life in knee osteoarthritis. Arthritis Rheumatol. 2015;67(12):3166–3173. doi:10.1002/art.39336

87. Hart HF, van Middelkoop M, Stefanik JJ, Crossley KM, Bierma-Zeinstra S. Obesity is related to incidence of patellofemoral osteoarthritis: the Cohort Hip and Cohort Knee (CHECK) study. Rheumatol Int. 2020;40(2):227–232. doi:10.1007/s00296-019-04472-9

88. Reyes C, Leyland KM, Peat G, Cooper C, Arden NK, Prieto-Alhambra D. Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis: a population-based cohort study. Arthritis Rheumatol. 2016;68(8):1869–1875. doi:10.1002/art.39707

89. Willy RW, Hoglund LT, Barton CJ, et al. Patellofemoral Pain. J Orthop Sports Phys Ther. 2019;49(9):CPG1–CPG95. doi:10.2519/jospt.2019.0302

90. Crossley KM, van Middelkoop M, Callaghan MJ, Collins NJ, Rathleff MS, Barton CJ. 2016 Patellofemoral pain consensus statement from the 4th International Patellofemoral Pain Research Retreat, Manchester. Part 2: recommended physical interventions (exercise, taping, bracing, foot orthoses and combined interventions). Br J Sports Med. 2016;50(14):844–852. doi:10.1136/bjsports-2016-096268

91. Collins NJ, Barton CJ, van Middelkoop M, et al. Consensus statement on exercise therapy and physical interventions (orthoses, taping and manual therapy) to treat patellofemoral pain: recommendations from the 5th International Patellofemoral Pain Research Retreat, Gold Coast, Australia, 2017. Br J Sports Med. 2018;52(18):1170–1178. doi:10.1136/bjsports-2018-099397

92. Souto LR, De Oliveira Silva D, Pazzinatto MF, Siqueira MS, Moreira RFC, Serrao FV. Are adjunct treatments effective in improving pain and function when added to exercise therapy in people with patellofemoral pain? A systematic review with meta-analysis and appraisal of the quality of interventions. Br J Sports Med. 2024;58(14):792–804. doi:10.1136/bjsports-2024-108145

93. Rathleff MS, Roos EM, Olesen JL, Rasmussen S. Exercise during school hours when added to patient education improves outcome for 2 years in adolescent patellofemoral pain: a cluster randomised trial. Br J Sports Med. 2015;49(6):406–412. doi:10.1136/bjsports-2014-093929

94. Barber P, Lack SD, Bartholomew C, et al. Patient experience of the diagnosis and management of patellofemoral pain: a qualitative exploration. Musculoskelet Sci Pract. 2022;57:102473. doi:10.1016/j.msksp.2021.102473

95. De Oliveira Silva D, Pazzinatto MF, Crossley KM, Azevedo FM, Barton CJ. Novel stepped care approach to provide education and exercise therapy for patellofemoral pain: feasibility study. J Med Internet Res. 2020;22(7):e18584. doi:10.2196/18584

96. Goff AJ, De Oliveira Silva D, Ezzat AM, et al. Co-design of the web-based ‘My Knee’ education and self-management toolkit for people with knee osteoarthritis. Digit Health. 2023;9:20552076231163810. doi:10.1177/20552076231163810

97. Souto LR, De Oliveira Silva D, Pazzinatto MF, Barton CJ. Beliefs of people with patellofemoral pain about their condition and treatments before and after self-directed access to a web-based education platform. Musculoskeletal Care. 2025;23(3):e70165. doi:10.1002/msc.70165

98. Atukorala I, Makovey J, Lawler L, Messier SP, Bennell K, Hunter DJ. Is there a dose-response relationship between weight loss and symptom improvement in persons with knee osteoarthritis? Arthritis Care Res. 2016;68(8):1106–1114. doi:10.1002/acr.22805

99. Zhang ZY, Tian L, He K, et al. Digital rehabilitation programs improve therapeutic exercise adherence for patients with musculoskeletal conditions: a systematic review with meta-analysis. J Orthop Sports Phys Ther. 2022;52(11):726–39.

100. Glaviano NR, Holden S, Bazett-Jones DM, Singe SM, Rathleff MS. Living well (or not) with patellofemoral pain: a qualitative study. Phys Ther Sport. 2022;56:1–7. doi:10.1016/j.ptsp.2022.05.011

101. Hart HF, Barton CJ, Khan KM, Riel H, Crossley KM. Is body mass index associated with patellofemoral pain and patellofemoral osteoarthritis? A systematic review and meta-regression and analysis. Br J Sports Med. 2017;51(10):781–790. doi:10.1136/bjsports-2016-096768

102. McVinnie DS. Obesity and pain. Br J Pain. 2013;7(4):163–170. doi:10.1177/2049463713484296

103. van der Heijden RA, de Kanter JL, Bierma-Zeinstra SM, et al. Structural abnormalities on magnetic resonance imaging in patients with patellofemoral pain: a cross-sectional case-control study. Am J Sports Med. 2016;44(9):2339–2346. doi:10.1177/0363546516646107

104. Grotle M, Hagen KB, Natvig B, Dahl FA, Kvien TK. Obesity and osteoarthritis in knee, Hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord. 2008;9:132. doi:10.1186/1471-2474-9-132

105. Carman WJ, Sowers M, Hawthorne VM, Weissfeld LA. Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study. Am J Epidemiol. 1994;139(2):119–129. doi:10.1093/oxfordjournals.aje.a116974

106. Shimizu H, Shimomura Y, Hayashi R, et al. Serum leptin concentration is associated with total body fat mass, but not abdominal fat distribution. Int J Obes Relat Metab Disord. 1997;21(7):536–541. doi:10.1038/sj.ijo.0800437

107. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83(3):847–850. doi:10.1210/jcem.83.3.4660

108. Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, Zurakowski A. Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity. Int J Obes Relat Metab Disord. 2000;24(11):1392–1395. doi:10.1038/sj.ijo.0801398

109. Ding C, Parameswaran V, Cicuttini F, et al. Association between leptin, body composition, sex and knee cartilage morphology in older adults: the Tasmanian older adult cohort (TASOAC) study. Ann Rheum Dis. 2008;67(9):1256–1261. doi:10.1136/ard.2007.082651

110. Hussain SM, Tan MC, Stathakopoulos K, et al. How are obesity and body composition related to patellar cartilage? A systematic review. J Rheumatol. 2017;44(7):1071–1082. doi:10.3899/jrheum.151384

111. Wang Y, Davies-Tuck ML, Wluka AE, et al. Dietary fatty acid intake affects the risk of developing bone marrow lesions in healthy middle-aged adults without clinical knee osteoarthritis: a prospective cohort study. Arthritis Res Ther. 2009;11(3):R63. doi:10.1186/ar2688

112. Barton CJ, Crossley KM, Macri EM. Should we consider changing traditional physiotherapy treatment of patellofemoral pain based on recent insights from the literature? Br J Sports Med. 2018;52(24):1546–1547. doi:10.1136/bjsports-2017-098695

113. 2020 - NICE-Osteoartrite.pdf.

114. Hall M, Castelein B, Wittoek R, Calders P, Van Ginckel A. Diet-induced weight loss alone or combined with exercise in overweight or obese people with knee osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2019;48(5):765–777. doi:10.1016/j.semarthrit.2018.06.005

115. Sala-Climent M, Lopez de Coca T, Guerrero MD, et al. The effect of an anti-inflammatory diet on chronic pain: a pilot study. Front Nutr. 2023;10:1205526. doi:10.3389/fnut.2023.1205526

116. Schell J, Scofield RH, Barrett JR, et al. Strawberries improve pain and inflammation in obese adults with radiographic evidence of knee osteoarthritis. Nutrients. 2017;9(9). doi:10.3390/nu9090949

117. Veronese N, Stubbs B, Noale M, Solmi M, Luchini C, Maggi S. Adherence to the mediterranean diet is associated with better quality of life: data from the osteoarthritis initiative. Am J Clin Nutr. 2016;104(5):1403–1409. doi:10.3945/ajcn.116.136390

118. Garcia-Morales JM, Lozada-Mellado M, Hinojosa-Azaola A, et al. Effect of a Dynamic exercise program in combination with mediterranean diet on quality of life in women with rheumatoid arthritis. J Clin Rheumatol. 2020;26(7S Suppl 2):S116–S122. doi:10.1097/RHU.0000000000001064

119. Morales-Ivorra I, Romera-Baures M, Roman-Vinas B, Serra-Majem L. Osteoarthritis and the mediterranean diet: a systematic review. Nutrients. 2018;10(8). doi:10.3390/nu10081030

120. Cooper I, Brukner P, Devlin BL, et al. An anti-inflammatory diet intervention for knee osteoarthritis: a feasibility study. BMC Musculoskelet Disord. 2022;23(1):47. doi:10.1186/s12891-022-05003-7

121. Harris A, Hinman RS, Lawford BJ, et al. Cost-effectiveness of telehealth-delivered exercise and dietary weight loss programs for knee osteoarthritis within a twelve-month randomized trial. Arthritis Care Res. 2023;75(6):1311–1319. doi:10.1002/acr.25022

122. Hart HF, Selkowitz DM, Nunes GS, et al. Bridging gaps in delivering high-value treatment for patellofemoral pain: A systematic evidence and gap map of interventions for patellofemoral pain. J Orthop Sports Phys Ther. 2026;56:2 98–108. doi:10.2519/jospt.2026.13511

123. Sköldstam L, Hagfors L, Johansson G. An experimental study of Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62:208–214.

124. Shin D, Hong SJ, Lee KW, Shivappa N, Hebert JR, Kim K. Pro-inflammatory diet associated with low back pain in adults aged 50 and older. Appl Nurs Res. 2022;66:151589. doi:10.1016/j.apnr.2022.151589

Creative Commons License © 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.